Scholar
Marketplace
Demo
Lab
Feedback
$
English
Sign In
Home
Search
My boards
Insights
Collaborators
Reader
Blog
Help
Scholar
Marketplace
Demo
Lab
Home
Search
My boards
Insights
Collaborators
Reader
Blog
Help
Precision medicine for cancer patients: lessons learned and the path forward.
Translate
Kyrgyz
Afrikaans
Amharic
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bengali
Bosnian
Български
Catalan
Cebuano
Chichewa
中文(简体)
中文(繁體)
Corsican
Croatian
Czech
Danish
Dutch
English
Esperanto
Estonian
Filipino
Finnish
Français
Frisian
Galician
Georgian
Deutsch
Greek
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hmong
Hungarian
Icelandic
Igbo
Indonesian
Irish
Italian
Japanese
Javanese
Kannada
Kazakh
Khmer
Korean
Kurdish (Kurmanji)
Albanian
Lao
Latin
Latvian
Lithuanian
Luxembourgish
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Myanmar (Burmese)
Nepali
Norwegian
Pashto
Persian
Polish
Portuguese
Punjabi
Romanian
Russian
Samoan
Scots Gaelic
Serbian
Sesotho
Shona
Sindhi
Sinhala
Slovak
Slovenian
Somali
Spanish
Sundanese
Swahili
Swedish
Tajik
Tamil
Telugu
Thai
Turkish
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
PDF (178K)
John Minna
Adi Gazdar
Journal:
2013/November
-
Journal of the National Cancer Institute
ISSN:
1460-2105
PUBMED:
23964132
DOI:
10.1093/jnci/djt219
PMC:
PMC3760782
Open in
PUBMED
|
DOI
|
PMC
|
Google Scholar
|
Wikipedia
Relations:
Citations
(6)
References
(10)
Patents
(9)
Grants
(269)
Chemicals
(1)
Diseases
(3)
Organisms
(1)
Anatomy
(1)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.
Drag-and-drop any entity to your messages.
Learn More
Search and select entities to see details here. Details will include lists of related entities (via publication). Explore related entities further.
Learn More